Related Experiment Video
Updated: Jan 23, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Cassia-Derived Natural Flavonoids as Multi-Target Candidates for Lung Cancer Therapy: A Network Pharmacology and
Zafer Saad Al Shehri1, Abdur Rehman2
1Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, 19257, Kingdom of Saudi Arabia.
Introduction:
Lung cancer remains a major global health burden with high mortality rates and limited therapeutic options. Natural flavonoids, particularly those derived from Cassia species, have shown immunomodulatory and anticancer potential. This study investigates the therapeutic promise of selected Cassia-derived flavonoids targeting key lung cancer-associated proteins: Prostaglandin-endoperoxide synthase 2 (PTGS2), Mast/stem cell growth factor receptor (KIT), and Xanthine dehydrogenase (XDH).
Methodology:
Eight flavonoids were selected based on literature and database-reported bioactivity. Target prediction was performed using SwissTargetPrediction and STITCH, followed by pathway enrichment via STRING and KEGG databases. Molecular docking was conducted using AutoDock Vina against PTGS2 (PDB: 5IKQ), KIT (1N5X), and XDH (4U0I). Top-ranked complexes underwent 100 ns molecular dynamics (MD) simulations with GROMACS to assess binding stability, RMSD, and conformational behavior. Drug-likeness, ADME, and toxicity profiles were evaluated using SwissADME and ProTox-II. Standard drugs (Trametinib, Nivolumab, Erlotinib) were used for comparison.
Results:
Epicatechin and Hispidulin showed the strongest binding affinities with PTGS2 (-9.04 kcal/mol) and XDH (-8.22 kcal/mol), respectively, with stable RMSD profiles. Chrysoeriol demonstrated the highest binding to KIT (-8.68 kcal/mol), outperforming Nivolumab (-6.03 kcal/mol). All selected flavonoids displayed acceptable pharmacokinetic profiles and low predicted toxicity. MD simulations confirmed the dynamic stability of key complexes.
Conclusion:
Cassia-derived flavonoids represent promising multi-target candidates for lung cancer therapy, particularly through modulation of PTGS2, KIT, and XDH. Their favorable interaction profiles and safety predictions warrant further experimental and in vivo validation.
Insights
Cassia flavonoids show promise as novel lung cancer treatments by targeting key proteins PTGS2, KIT, and XDH. These natural compounds exhibit favorable binding and safety profiles, suggesting potential for new therapies.
Area of Science:
- Pharmacology
- Computational Chemistry
- Oncology
Background:
- Lung cancer presents a significant global health challenge with limited treatment options.
- Natural flavonoids, especially from Cassia species, possess immunomodulatory and anticancer properties.
- This study explores Cassia flavonoids as potential therapeutics targeting key lung cancer proteins.
Purpose of the Study:
- To investigate the therapeutic potential of selected Cassia-derived flavonoids against lung cancer.
- To identify specific protein targets (PTGS2, KIT, XDH) modulated by these flavonoids.
- To evaluate the binding affinity, stability, and drug-like properties of these compounds.
Main Methods:
- Selected eight flavonoids based on literature and database bioactivity.
- Utilized computational tools (SwissTargetPrediction, STITCH, STRING, KEGG) for target prediction and pathway analysis.
- Performed molecular docking and 100 ns molecular dynamics simulations, followed by ADME/toxicity assessments.
Main Results:
- Epicatechin and Hispidulin demonstrated strong binding to PTGS2 and XDH, respectively.
- Chrysoeriol exhibited superior binding affinity to KIT compared to a standard drug.
- All evaluated flavonoids showed acceptable pharmacokinetic profiles and low predicted toxicity.
Conclusions:
- Cassia-derived flavonoids are promising multi-target agents for lung cancer therapy.
- Modulation of PTGS2, KIT, and XDH by these flavonoids warrants further investigation.
- Favorable interaction and safety profiles support continued experimental and in vivo validation.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Molecular Models
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

